Ruben Mesa, MD
Advertisement
Articles by Ruben Mesa, MD
Advertisement
Latest Updated Articles
Making a Differential Diagnosis of MyelofibrosisPublished: May 12th 2022 | Updated:
Factors in Selecting Therapy for MyelofibrosisPublished: May 26th 2022 | Updated:
Overview on Essential Thrombocythemia and Polycythemia Vera ManagementPublished: December 22nd 2022 | Updated:
- Use of Ruxolitinib in Myelofibrosis
Published: June 2nd 2022 | Updated:
Dr. Mesa on the Rationale for the Earlier Use of Ruxolitinib in MyelofibrosisPublished: October 16th 2020 | Updated:
- Clinical Pearls for the Management of Myelofibrosis
Published: June 23rd 2022 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
Orca-T With Reduced-Intensity Conditioning Yields Robust Efficacy in Hematologic Malignancies
4
TRX103 Tr1 Cell Therapy Shows Manageable Safety and Dose-Dependent Kinetics After HLA-Mismatched HCT in Hematologic Malignancies
5